References
- Castleman B. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9:822–30.
- Frizzera G. Castleman’s disease and related disorders. Semin Diagn Pathol. 1988;5:346–64.
- Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki. 2010;51:320–5. (in Japanese).
- Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y, et al. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016;103:686–92.
- Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S, et al. Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meeting (22 September, 2012). J Clin Expo Hematop. 2013;53:57–61.
- Iwaki N, Sato Y, Takata K, Kondo E, Ohno K, Takeuchi M, et al. Atypical Hyaline Vascular-Type Castleman’s disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy. J Clin Exp Hematop. 2013;53:87–93.
- Kubokawa I, Yachie A, Hayakawa A, Hirase S, Yamamoto N, Mori T, et al. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman’s disease. BMC Pediatrics. 2014;14:139.
- Kawabata H, Kotai S, Matsumura Y, Kondo T, Katsurada T, Haga H, et al. Successful treatment of a patient with Multicentric Castleman’s disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody. Intern Med. 2013;52:1503–7.
- Fufiwara S, Mochinaga H, Nakata H, Ohshima K, Matsumoto M, Uchiba M, et al. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids. Int J Hematol. 2016;103:718–23.
- Koduri PR, Parvez M, Kaza S, Pappu P, Anuradha S. Castleman-Kojima disease in a South Asian adolescent. J Clin Expo Hematop. 2014;54:163–6.
- Vogler JB III, Murphy WA. Bone marrow imaging. Radiology. 1988;168:679–93.
- Lanir A, Aghai E, Simon JS, Lee RGL, Glouse ME. MR imaging in myelofibrosis. J Comput Assist Tomogr. 1986;10:634–6.
- Lanir A, Hadar H, Cohen I, Tal Y, Benmair J, Schreiber R, et al. Gaucher disease: assessment with MR imaging. Radiology. 1986;161:239–44.
- Cohen MD, Klatte EC, Baehner R, Smith JA, Martin-Simmerman P, Carr BE, et al. Magnetic resonance imaging of bone marrow disease in children. Radiology. 1984;151:715–8.
- Moulopoulos LA, Koutoulidis V. Bone marrow MRI: a pattern-based approach. Milan: Springer-Verlag Italia; 2015:101–14.
- Stabler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. AJR Am J Roentgenol. 1996;167:1029–36.
- Kricun ME. Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skeletal Radiol. 1985;14:10–19.
- Hartman RP, Sundaram M, Okuno SH, Sim FH. Effect of granulocyte-stimulating factors on marrow of adult patients with musculoskeletal malignancies: incidence and MRI findings. AJR Am J Roentgenol. 2004;183:645–53.
- Gruol DL, Nelson TE. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol. 1997;15:307–9.
- Sakai K, Maeda T, Kuriyama A, Shimada N, Notohara K, Uida Y. TAFRO syndrome successfully treated with tocilizumab: a case report and systemic review. Mod Rheumatol. 2016;17:1–6.
- El Karoui K, Vuiblet V, Dion D, Izzedine H, Guitard J, Frimat L, et al. Renal involvement in Castleman disease. Nephrol Dial Transplant. 2011;26:599–609.
- Xu D, Lv J, Dong Y, Wang S, Su T, Zhou F, et al. Renal involvement in a large cohort of Chinese patients with Castleman disease. Nephrol Dial Transplant. 2012;27(Suppl 3):119–25.